130 related articles for article (PubMed ID: 26812916)
1. The Adverse Effects of Smoking on Health Outcomes in Bipolar Disorder: A Review and Synthesis of Biological Mechanisms.
Slyepchenko A; Brunoni AR; McIntyre RS; Quevedo J; Carvalho AF
Curr Mol Med; 2016; 16(2):187-205. PubMed ID: 26812916
[TBL] [Abstract][Full Text] [Related]
2. Inflammation as a Mechanism of Bipolar Disorder Neuroprogression.
Barichello T; Giridharan VV; Bhatti G; Sayana P; Doifode T; Macedo D; Quevedo J
Curr Top Behav Neurosci; 2021; 48():215-237. PubMed ID: 33040314
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers and staging of bipolar disorder: a systematic review.
Roda Â; Chendo I; Kunz M
Trends Psychiatry Psychother; 2015; 37(1):3-11. PubMed ID: 25860561
[TBL] [Abstract][Full Text] [Related]
4. Staging and neuroprogression in bipolar disorder.
Fries GR; Pfaffenseller B; Stertz L; Paz AV; Dargél AA; Kunz M; Kapczinski F
Curr Psychiatry Rep; 2012 Dec; 14(6):667-75. PubMed ID: 23090632
[TBL] [Abstract][Full Text] [Related]
5. Peripheral markers of oxidative stress and antioxidative defense in euthymia of bipolar disorder--Gender and obesity effects.
Bengesser SA; Lackner N; Birner A; Fellendorf FT; Platzer M; Mitteregger A; Unterweger R; Reininghaus B; Mangge H; Wallner-Liebmann SJ; Zelzer S; Fuchs D; McIntyre RS; Kapfhammer HP; Reininghaus EZ
J Affect Disord; 2015 Feb; 172():367-74. PubMed ID: 25451439
[TBL] [Abstract][Full Text] [Related]
6. Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways.
Anderson G; Jacob A; Bellivier F; Geoffroy PA
Curr Pharm Des; 2016; 22(8):987-1012. PubMed ID: 26654772
[TBL] [Abstract][Full Text] [Related]
7. Staging and neuroprogression in bipolar disorder: a systematic review of the literature.
Gama CS; Kunz M; Magalhães PV; Kapczinski F
Braz J Psychiatry; 2013 Mar; 35(1):70-4. PubMed ID: 23567604
[TBL] [Abstract][Full Text] [Related]
8. Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder.
Bortolasci CC; Vargas HO; Souza-Nogueira A; Barbosa DS; Moreira EG; Nunes SO; Berk M; Dodd S; Maes M
J Affect Disord; 2014 Apr; 159():23-30. PubMed ID: 24679385
[TBL] [Abstract][Full Text] [Related]
9. The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence.
Nunes SO; Vargas HO; Prado E; Barbosa DS; de Melo LP; Moylan S; Dodd S; Berk M
Neurosci Biobehav Rev; 2013 Sep; 37(8):1336-45. PubMed ID: 23660457
[TBL] [Abstract][Full Text] [Related]
10. Biological hypotheses and biomarkers of bipolar disorder.
Sigitova E; Fišar Z; Hroudová J; Cikánková T; Raboch J
Psychiatry Clin Neurosci; 2017 Feb; 71(2):77-103. PubMed ID: 27800654
[TBL] [Abstract][Full Text] [Related]
11. Areas of controversy in neuroprogression in bipolar disorder.
Passos IC; Mwangi B; Vieta E; Berk M; Kapczinski F
Acta Psychiatr Scand; 2016 Aug; 134(2):91-103. PubMed ID: 27097559
[TBL] [Abstract][Full Text] [Related]
12. Diet and Bipolar Disorder: A Review of Its Relationship and Potential Therapeutic Mechanisms of Action.
Lopresti AL; Jacka FN
J Altern Complement Med; 2015 Dec; 21(12):733-9. PubMed ID: 26348597
[TBL] [Abstract][Full Text] [Related]
13. Biological Pathways Associated with Neuroprogression in Bipolar Disorder.
Wollenhaupt-Aguiar B; Kapczinski F; Pfaffenseller B
Brain Sci; 2021 Feb; 11(2):. PubMed ID: 33673277
[TBL] [Abstract][Full Text] [Related]
14. Novel biomarkers for bipolar disorder.
Teixeira AL; Barbosa IG; Machado-Vieira R; Rizzo LB; Wieck A; Bauer ME
Expert Opin Med Diagn; 2013 Mar; 7(2):147-59. PubMed ID: 23530885
[TBL] [Abstract][Full Text] [Related]
15. The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research.
Rizzo LB; Costa LG; Mansur RB; Swardfager W; Belangero SI; Grassi-Oliveira R; McIntyre RS; Bauer ME; Brietzke E
Neurosci Biobehav Rev; 2014 May; 42():157-69. PubMed ID: 24548785
[TBL] [Abstract][Full Text] [Related]
16. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications.
Rosenblat JD; Brietzke E; Mansur RB; Maruschak NA; Lee Y; McIntyre RS
J Affect Disord; 2015 Dec; 188():149-59. PubMed ID: 26363613
[TBL] [Abstract][Full Text] [Related]
17. TLR4 gene polymorphism associated with lifetime cigarette smoking in bipolar disorder.
Zerdazi EH; Oliveira J; Vorspan F; Bennabi M; Jamain S; Etain B; Leboyer M; Tamouza R; Bellivier F
J Neuroimmunol; 2017 Apr; 305():96-101. PubMed ID: 28284355
[TBL] [Abstract][Full Text] [Related]
18. Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder.
Rotondo A; Mazzanti C; Dell'Osso L; Rucci P; Sullivan P; Bouanani S; Gonnelli C; Goldman D; Cassano GB
Am J Psychiatry; 2002 Jan; 159(1):23-9. PubMed ID: 11772685
[TBL] [Abstract][Full Text] [Related]
19. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.
Berk M; Kapczinski F; Andreazza AC; Dean OM; Giorlando F; Maes M; Yücel M; Gama CS; Dodd S; Dean B; Magalhães PV; Amminger P; McGorry P; Malhi GS
Neurosci Biobehav Rev; 2011 Jan; 35(3):804-17. PubMed ID: 20934453
[TBL] [Abstract][Full Text] [Related]
20. Refractory bipolar disorder and neuroprogression.
da Costa SC; Passos IC; Lowri C; Soares JC; Kapczinski F
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():103-10. PubMed ID: 26368941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
